Cargando…

Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor

PURPOSE: The purpose of the study was to assess the efficacy of TIP as salvage chemotherapy for germ cell tumor (GCT) patients with relapsed disease or cisplatin (CDDP)-refractory disease and consolidation chemotherapy for patients who responded unfavorably to first-line chemotherapy. METHODS: Forty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurobe, Masahiro, Kawai, Koji, Oikawa, Takehiro, Ichioka, Daishi, Kandori, Shuya, Takaoka, Ei-ichirou, Kojima, Takahiro, Joraku, Akira, Suetomi, Takahiro, Miyazaki, Jun, Nishiyama, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282876/ https://www.ncbi.nlm.nih.gov/pubmed/25062721 http://dx.doi.org/10.1007/s00432-014-1760-x

Ejemplares similares

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
por: von Amsberg, Gunhild, et al.
Publicado: (2022)

Retroperitoneal lymph node dissection for testicular cancer in a patient with a double inferior vena cava
por: Yamaguchi, Akane, et al.
Publicado: (2021)

Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors
por: Kawahara, Takashi, et al.
Publicado: (2022)

Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples
por: Kurobe, Masahiro, et al.
Publicado: (2016)

Impact of Early Exposure to Simulation Program on Undergraduate Medical Students’ Interest in Urology
por: Kimura, Tomokazu, et al.
Publicado: (2021)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial
por: Mead, G M, et al.
Publicado: (2005)

Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin
por: Kandori, Shuya, et al.
Publicado: (2018)

Ogilvie Syndrome in a Refractory Germ Cell Tumor Treated with Vinblastine, Ifosfamide and Cisplatin Regimen
por: Varayathu, Hrishi, et al.
Publicado: (2020)

Whole-Blood Gene Expression Profiles Correlate with Response to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma
por: Nagumo, Yoshiyuki, et al.
Publicado: (2022)

Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
por: Hamada, Kazuki, et al.
Publicado: (2023)

Sperm cryopreservation: Clinical and fertility outcomes in male oncological patients with germ cell tumors or hematological disorders
por: Negoro, Hiromitsu, et al.
Publicado: (2018)

Salvage therapy of germ cell tumours.
por: Horwich, A.
Publicado: (1995)

Great Toe Necrosis Predicts an Unfavorable Limb Salvage Prognosis
por: Sano, Hitomi, et al.
Publicado: (2014)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

Mediating effect assessment of ifosfamide on limb salvage rate in osteosarcoma: A study from a single center in China
por: Li, Yan, et al.
Publicado: (2022)

Salvage treatment in male patients with germ cell tumours.
por: Josefsen, D., et al.
Publicado: (1993)

TRPV4-dependent induction of a novel mammalian cold-inducible protein SRSF5 as well as CIRP and RBM3
por: Fujita, Takanori, et al.
Publicado: (2017)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
por: Mehrzad, Valiollah, et al.
Publicado: (2017)

Combination of ifosfamide and etoposide as a salvage regimen for previously treated soft tissue sarcomas: a retrospective single centre study
por: Ribeiro, Luiz Fernando, et al.
Publicado: (2022)

Response to ifosfamide, carboplatin, etoposide (ICE) vs. dexamethasone, cytarabine cisplatin (DHAP) as salvage chemotherapy in patients with relapsed/refractory lymphoma
por: Devi, Kanta, et al.
Publicado: (2023)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

Combustion Synthesis of Porous TiC/Ti Composite by a Self-Propagating Mode
por: Kobashi, Makoto, et al.
Publicado: (2010)

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma
por: Tomono, Ayana, et al.
Publicado: (2016)

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
por: Leyvraz, S, et al.
Publicado: (2006)

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma
por: Bücklein, Veit, et al.
Publicado: (2020)

Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan
por: Koizumi, Chie, et al.
Publicado: (2014)

Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model
por: Yoshino, Takayuki, et al.
Publicado: (2019)

Case Report: Molecular Characterization of Aggressive Malignant Retroperitoneal Solitary Fibrous Tumor: A Case Study
por: Nonaka, Haruna, et al.
Publicado: (2021)

Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer
por: Kosmas, C, et al.
Publicado: (2009)

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
por: Sokolova, Alexandra, et al.
Publicado: (2017)

Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
por: Van der Speeten, Kurt, et al.
Publicado: (2011)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Ifosfamide-Induced Malignancy of Ureter and Bladder
por: Sannu, Aparna, et al.
Publicado: (2017)

Partial Fanconi Syndrome Induced by Ifosfamide
por: Das, Sulagna, et al.
Publicado: (2019)

Ifosfamide as a Cause of Fanconi Syndrome
por: Martinez, Daniel, et al.
Publicado: (2022)

ELOVL5‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma
por: Nitta, Satoshi, et al.
Publicado: (2022)

Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
por: Kato, Renpei, et al.
Publicado: (2022)

Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
por: Kato, Renpei, et al.
Publicado: (2023)

Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours
por: De Giorgi, U, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_nel485k48ompah9337dbf3v4ss